Working… Menu

Procalcitonin Level and Kinetics in Children With Bacterial Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00714402
Recruitment Status : Completed
First Posted : July 14, 2008
Last Update Posted : May 18, 2011
Information provided by:
Shaare Zedek Medical Center

Brief Summary:

The purposes of this study are:

  1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length
  2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever

Condition or disease
Bacterial Infections Bacteremia Meningitis Urinary Tract Infection Mastoiditis Lobar Pneumonia Septic Arthritis Cellulitis Osteomyelitis

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections
Study Start Date : August 2008

Resource links provided by the National Library of Medicine

children with proven of probable invasive bacterial infections

Primary Outcome Measures :
  1. time to defervescence [ Time Frame: discharge ]

Secondary Outcome Measures :
  1. length of hospitalization [ Time Frame: discharge ]

Biospecimen Retention:   None Retained
whole blood

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
hospitalized patients at date of admission

Inclusion Criteria:

  • Positive blood, urine, synovial, bone, pleural effusion, abscess or CSF culture
  • Cellulitis, lobar pneumonia, osteomyelitis,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00714402

Layout table for location information
Shaare Zedek Medical Center
Jerusalem, Pob 3235, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Layout table for investigator information
Principal Investigator: Yechiel Schlesinger, MD Shaare Zedek Medical Center


Layout table for additonal information
Responsible Party: Yechiel Schlesinger, Shaare Zedek Medical Center Identifier: NCT00714402     History of Changes
Other Study ID Numbers: pct.ctil
First Posted: July 14, 2008    Key Record Dates
Last Update Posted: May 18, 2011
Last Verified: January 2009
Keywords provided by Shaare Zedek Medical Center:
Additional relevant MeSH terms:
Layout table for MeSH terms
Communicable Diseases
Urinary Tract Infections
Bacterial Infections
Arthritis, Infectious
Joint Diseases
Musculoskeletal Diseases
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Urologic Diseases
Central Nervous System Diseases
Nervous System Diseases
Systemic Inflammatory Response Syndrome
Pathologic Processes
Bone Diseases, Infectious
Bone Diseases
Skin Diseases, Infectious
Connective Tissue Diseases
Otitis Media